Kintor, Fosun partner to commercialise proxalutamide in India and Africa
The collaboration will focus on the emergency use authorisation, promotion, and sale of proxalutamide for the treatment of…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Jul 21
The collaboration will focus on the emergency use authorisation, promotion, and sale of proxalutamide for the treatment of…
18 Jun 21
Under the deal, BMS will develop and commercialise the drug in regions outside of the collaboration territories, while…
14 Jun 21
The partnership with Tabuk will expand the global access to Moderna’s vaccine and supports the Covid-19 vaccine availability…
11 Jun 21
Verona is currently studying ensifentrine in a global Phase 3 programme in the US, Europe and South Korea,…
01 Jun 21
The agreement will enable Innovent to co-develop and commercialise AnHeart’ taletrectinib in Greater China, including mainland China, Hong…
24 May 21
Equipped with advanced production lines, Samsung Biologics' facilities will support the production of hundreds of millions of doses…
20 May 21
The collaboration will deploy AI to advance the discovery of small molecule therapeutic drug candidates in multiple therapeutic…
20 May 21
The new cGMP facility will be designed to provide an end-to-end solution to advance cell therapy development and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
17 May 21
Under the agreement, Chime Biologics will produce lenzilumab bulk drug substance and drug product for Humanigen for commercial…
11 May 21
Baricitinib, a once-daily, oral medication was discovered by US-based Incyte and licensed to Eli Lilly